Summary of sharing of data and code for Li et al., "Durability of Neutralizing and Anti-Spike Binding IgG Antibody Responses to Monovalent (D614) and Bivalent (D614 + B.1.351) AS03-Adjuvanted SARS-CoV-2 Recombinant Protein Vaccines."
Li Li
March 14, 2026
- All analyses are based on the analysis-ready data files
vat08_combined_data_processed_longitudinal_bAb.csvandvat08_combined_data_processed_longitudinal_nAb.csv. - A single statistical report includes all the main figures and tables. A copy of the statistical report is on the SCHARP network drive
T:\covpn\p3005\analysis\antibody_durability
nAb-ID50 titers against Omicron BA.4/BA.5 and bAb-IgG Spike concentrations against Omicron before detected SARS-CoV-2 infection in the nAb and bAb longitudinal analysis cohorts, separately by stage, treatment arm, and Naïve vs. Non-naïve status.
Statistical report: vat08_antibody_durability_ms.pdf
-
Data were extracted from page 2.
-
To reproduce this report, follow the following instructions:
# a) download the zip file that contains the code from https://github.com/CoVPN/vat08-antibody-durability
# b) install R packages
# Assume that R 4.4.3 and R package `remotes` have been installed
R
remotes::install_version("tidyverse", version = "2.0.0")
remotes::install_version("plyr", version = "1.8.9")
remotes::install_version("lme4", version = "1.1-37")
remotes::install_version("doParallel", version = "1.0.17")
remotes::install_version("doRNG", version = "1.8.6.1")
remotes::install_version("ggplot2", version = "3.5.2")
remotes::install_version("scales", version = "1.4.0")
# c) set the directory
R
setwd("~/vat08-antibody-durability-master")
repoDir <- here::here()
# d) source R files
R
source(file.path(repoDir, "code/desc/descFig.R"))
source(file.path(repoDir, "code/LMMmodeling/confidenceInt.R")) # 35 cores were used for parallel computing in this call; to set a different number of cores, modify `registerDoParallel(35)`
source(file.path(repoDir, "code/LMMmodeling/permutationTest.R")) # 35 cores were used for parallel computing in this call; to set a different number of cores, modify `registerDoParallel(35)`
source(file.path(repoDir, "code/LMMmodeling/FittedTrajectoryPlot.R"))
source(file.path(repoDir, "code/summary/summary.R"))
# e) generate report pdf
R
rmarkdown::render(file.path(repoDir, "code/vat08_antibody_durability_ms.Rmd"),
output_file = file.path(repoDir, "code/vat08_antibody_durability_ms.pdf"), quiet=TRUE)
Empirical geometric mean (GM) nAb-ID50 titers against BA.4/5 and against Reference and fitted linear mixed models by treatment arm and stage for the Non-naïve groups in the nAb longitudinal analysis cohort. Estimated D43 GM nAb-ID50 titers, durability, and D202-to-D43 geometric mean ratios (GMR) by treatment arm, with estimated vaccine-to-placebo ratios (95% CI).
Statistical report: vat08_antibody_durability_ms.pdf
- Data were extracted from page 3 and 4.
Empirical geometric mean (GM) bAb-IgG Spike concentrations against Omicron and against the Index strain and fitted linear mixed models by treatment arm and stage for the Non-naïve groups in the bAb longitudinal analysis cohort. Estimated D43 GM bAb-IgG Spike concentrations, durability, and D202-to-D43 geometric mean ratios (GMR) by treatment arm, with estimated vaccine-to-placebo ratios (95% CI).
Statistical report: vat08_antibody_durability_ms.pdf
- Data were extracted from page 5 and 6.
Empirical geometric mean (GM) nAb-ID50 titers among Non-naive participants and Naive participants and fitted linear mixed models by Naive/Non-naive status and stage in the nAb longitudinal analysis cohort. Estimated D43 GM nAb-ID50 titers, durability, and D202-to-D43 geometric mean ratios (GMR), with estimated BV-to-MV ratios (95% CI).
Statistical report: vat08_antibody_durability_ms.pdf
- Data were extracted from page 7 and 8.
Empirical geometric mean (GM) bAb-IgG Spike concentrations among Non-naive participants and Naive participants and fitted linear mixed models by Naive/Non-naive status and stage in the bAb longitudinal analysis cohort. Estimated D43 GM bAb-IgG Spike concentrations, durability, and D202-to-D43 geometric mean ratios (GMR), with estimated BV-to-MV ratios (95% CI).
Statistical report: vat08_antibody_durability_ms.pdf
- Data were extracted from page 9 and 10.
Comparisons of estimated geometric mean (GM) D43 antibody marker levels, durability, and D202-to-D43 geometric mean ratio (GMR)s between the Non-naïve vaccine and Naïve vaccine recipients in the nAb and bAb longitudinal analysis cohorts.
Statistical report: vat08_antibody_durability_ms.pdf
- Data were extracted from page 11.